HEADER TRANSFERASE 17-SEP-13 4C61 TITLE INHIBITORS OF JAK2 KINASE DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: KINASE DOMAIN RESIDUES 835-1132; COMPND 5 SYNONYM: JANUS KINASE 2, JAK-2; COMPND 6 EC: 2.7.1.112; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: STAR; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PT7 3.3 KEYWDS KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.A.READ,I.GREEN,H.POLLARD,T.HOWARD REVDAT 3 28-JUN-17 4C61 1 REMARK REVDAT 2 22-JAN-14 4C61 1 JRNL REVDAT 1 08-JAN-14 4C61 0 JRNL AUTH Q.SU,S.IOANNIDIS,C.CHUAQUI,L.ALMEIDA,M.ALIMZHANOV, JRNL AUTH 2 G.BEBERNITZ,K.BELL,M.BLOCK,T.HOWARD,S.HUANG,D.HUSZAR, JRNL AUTH 3 J.A.READ,C.RIVARD COSTA,J.SHI,M.SU,M.YE,M.ZINDA JRNL TITL DISCOVERY OF 1-METHYL-1H-IMIDAZOLE DERIVATIVES AS POTENT JRNL TITL 2 JAK2 INHIBITORS. JRNL REF J.MED.CHEM. V. 57 144 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 24359159 JRNL DOI 10.1021/JM401546N REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.IOANNIDIS,M.L.LAMB,T.WANG,L.ALMEIDA,M.H.BLOCK,A.M.DAVIES, REMARK 1 AUTH 2 B.PENG,M.SU,H.ZHANG,E.HOFFMANN,C.RIVARD,I.GREEN,T.HOWARD, REMARK 1 AUTH 3 H.POLLARD,J.READ,M.ALIMZHANOV,G.BEBERNITZ,K.BELL,M.YE, REMARK 1 AUTH 4 D.HUSZAR,M.ZINDA REMARK 1 TITL DISCOVERY OF REMARK 1 TITL 2 5-CHLORO-N2-[(1S)-1-(5-FLUOROPYRIMIDIN-2-YL) REMARK 1 TITL 3 ETHYL]-N4-(5-METHYL-1H-PYRAZOL-3-YL)PYRIMIDINE-2,4-DIAMINE REMARK 1 TITL 4 (AZD1480) AS A NOVEL INHIBITOR OF THE JAK/STAT PATHWAY. REMARK 1 REF J.MED.CHEM. V. 54 262 2011 REMARK 1 REFN ISSN 0022-2623 REMARK 1 PMID 21138246 REMARK 1 DOI 10.1021/JM1011319 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 25920 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1305 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.55 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.99 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2895 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2137 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2759 REMARK 3 BIN R VALUE (WORKING SET) : 0.2118 REMARK 3 BIN FREE R VALUE : 0.2498 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 136 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4398 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 199 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 56.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.52720 REMARK 3 B22 (A**2) : 1.92970 REMARK 3 B33 (A**2) : 2.59760 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.92890 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.341 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.350 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.223 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.357 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.227 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.947 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.927 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4556 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6165 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1563 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 111 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 711 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4556 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 571 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5260 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.12 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.12 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.77 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 7.6154 13.3377 45.5201 REMARK 3 T TENSOR REMARK 3 T11: -0.1267 T22: -0.0547 REMARK 3 T33: -0.1231 T12: 0.0333 REMARK 3 T13: 0.0695 T23: -0.0861 REMARK 3 L TENSOR REMARK 3 L11: 0.8077 L22: 3.6833 REMARK 3 L33: 3.2216 L12: -0.1374 REMARK 3 L13: 0.0804 L23: 1.3432 REMARK 3 S TENSOR REMARK 3 S11: 0.0723 S12: -0.1039 S13: 0.0184 REMARK 3 S21: 0.3134 S22: -0.4731 S23: 0.3597 REMARK 3 S31: -0.0699 S32: -0.4714 S33: 0.4008 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): -9.8631 -12.5591 20.9988 REMARK 3 T TENSOR REMARK 3 T11: -0.0482 T22: -0.0705 REMARK 3 T33: -0.0914 T12: 0.1159 REMARK 3 T13: 0.0021 T23: -0.0091 REMARK 3 L TENSOR REMARK 3 L11: 1.9811 L22: 1.0098 REMARK 3 L33: 2.2355 L12: 0.0456 REMARK 3 L13: -0.9999 L23: -0.4106 REMARK 3 S TENSOR REMARK 3 S11: -0.2897 S12: -0.1444 S13: -0.1813 REMARK 3 S21: 0.1126 S22: 0.0255 S23: -0.1570 REMARK 3 S31: 0.4073 S32: 0.3112 S33: 0.2642 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4C61 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 17-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1290058375. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25971 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450 REMARK 200 RESOLUTION RANGE LOW (A) : 134.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 200 DATA REDUNDANCY : 4.200 REMARK 200 R MERGE (I) : 0.07000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 13.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2XA4 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.86 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 21.94000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 63.54500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 21.94000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 63.54500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 835 REMARK 465 PHE A 836 REMARK 465 GLU A 837 REMARK 465 ASP A 838 REMARK 465 ARG A 839 REMARK 465 ASP A 840 REMARK 465 PRO A 841 REMARK 465 THR A 842 REMARK 465 GLN A 843 REMARK 465 LYS A 857 REMARK 465 GLY A 858 REMARK 465 ASN A 859 REMARK 465 PHE A 860 REMARK 465 SER A 919 REMARK 465 ALA A 920 REMARK 465 GLY A 921 REMARK 465 ARG A 922 REMARK 465 ARG A 923 REMARK 465 LYS A 1011 REMARK 465 GLU A 1012 REMARK 465 PRO A 1013 REMARK 465 GLY A 1014 REMARK 465 ALA A 1131 REMARK 465 GLY A 1132 REMARK 465 ALA B 835 REMARK 465 PHE B 836 REMARK 465 GLU B 837 REMARK 465 ASP B 838 REMARK 465 ARG B 839 REMARK 465 ASP B 840 REMARK 465 PRO B 841 REMARK 465 THR B 842 REMARK 465 GLN B 885 REMARK 465 HIS B 886 REMARK 465 SER B 887 REMARK 465 THR B 888 REMARK 465 GLU B 889 REMARK 465 GLU B 890 REMARK 465 TYR B 918 REMARK 465 SER B 919 REMARK 465 ALA B 920 REMARK 465 GLY B 921 REMARK 465 ARG B 922 REMARK 465 ARG B 923 REMARK 465 ASN B 924 REMARK 465 GLY B 1132 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 846 CG CD OE1 OE2 REMARK 470 LYS A 850 CG CD CE NZ REMARK 470 GLN A 872 CG CD OE1 NE2 REMARK 470 GLN A 885 CG CD OE1 NE2 REMARK 470 HIS A 886 CG ND1 CD2 CE1 NE2 REMARK 470 GLU A 889 CG CD OE1 OE2 REMARK 470 GLU A 890 CG CD OE1 OE2 REMARK 470 ARG A 893 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 912 CG CD CE NZ REMARK 470 GLU A 946 CG CD OE1 OE2 REMARK 470 ARG A 947 NE CZ NH1 NH2 REMARK 470 GLN A1003 CG CD OE1 NE2 REMARK 470 GLU A1015 CG CD OE1 OE2 REMARK 470 LYS A1053 CG CD CE NZ REMARK 470 GLN A1070 CG CD OE1 NE2 REMARK 470 PHE A1076 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A1083 CG CD CE NZ REMARK 470 ARG A1117 CG CD NE CZ NH1 NH2 REMARK 470 LEU A1121 CG CD1 CD2 REMARK 470 GLN A1125 CG CD OE1 NE2 REMARK 470 GLN A1129 CG CD OE1 NE2 REMARK 470 GLN B 843 CG CD OE1 NE2 REMARK 470 GLU B 846 CG CD OE1 OE2 REMARK 470 ARG B 847 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 850 CG CD CE NZ REMARK 470 LYS B 857 CG CD CE NZ REMARK 470 ASN B 859 CG OD1 ND2 REMARK 470 PHE B 860 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN B 872 CG CD OE1 NE2 REMARK 470 LYS B 883 CG CD CE NZ REMARK 470 GLN B 906 CD OE1 NE2 REMARK 470 LYS B 912 CG CD CE NZ REMARK 470 GLU B 946 CG CD OE1 OE2 REMARK 470 LYS B1011 CG CD CE NZ REMARK 470 GLU B1012 CG CD OE1 OE2 REMARK 470 GLU B1015 CG CD OE1 OE2 REMARK 470 LYS B1053 CG CD CE NZ REMARK 470 GLN B1070 CG CD OE1 NE2 REMARK 470 GLN B1072 CG CD OE1 NE2 REMARK 470 GLN B1129 CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 869 76.14 -117.92 REMARK 500 LEU A 871 48.16 -93.17 REMARK 500 GLN A 872 95.60 6.81 REMARK 500 ASP A 873 7.70 -173.09 REMARK 500 HIS A 886 73.52 -102.26 REMARK 500 ARG A 975 -7.24 72.40 REMARK 500 ASP A 976 38.30 -142.90 REMARK 500 TRP A1106 40.82 -92.39 REMARK 500 ASN B 874 -0.10 81.43 REMARK 500 ARG B 975 -7.39 71.18 REMARK 500 GLU B1012 71.74 -118.71 REMARK 500 TRP B1106 40.65 -92.90 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B2012 DISTANCE = 7.10 ANGSTROMS REMARK 525 HOH B2014 DISTANCE = 6.34 ANGSTROMS REMARK 525 HOH B2030 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH B2136 DISTANCE = 8.09 ANGSTROMS REMARK 525 HOH B2137 DISTANCE = 6.51 ANGSTROMS REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 ACT A 2134 REMARK 610 ACT A 2135 REMARK 610 ACT B 3135 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LMM A 2133 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LMM B 3134 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 3135 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 2134 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 2135 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4C62 RELATED DB: PDB REMARK 900 INHIBITORS OF JAK2 KINASE DOMAIN REMARK 999 REMARK 999 SEQUENCE REMARK 999 K943 AND K945A DOUBLE MUTANT DBREF 4C61 A 835 1132 UNP O60674 JAK2_HUMAN 835 1132 DBREF 4C61 B 835 1132 UNP O60674 JAK2_HUMAN 835 1132 SEQADV 4C61 ALA A 943 UNP O60674 LYS 943 ENGINEERED MUTATION SEQADV 4C61 ALA A 945 UNP O60674 LYS 945 ENGINEERED MUTATION SEQADV 4C61 ALA B 943 UNP O60674 LYS 943 ENGINEERED MUTATION SEQADV 4C61 ALA B 945 UNP O60674 LYS 945 ENGINEERED MUTATION SEQRES 1 A 298 ALA PHE GLU ASP ARG ASP PRO THR GLN PHE GLU GLU ARG SEQRES 2 A 298 HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE SEQRES 3 A 298 GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP SEQRES 4 A 298 ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SEQRES 5 A 298 SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE SEQRES 6 A 298 GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS SEQRES 7 A 298 TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU SEQRES 8 A 298 LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG SEQRES 9 A 298 ASP TYR LEU GLN ALA HIS ALA GLU ARG ILE ASP HIS ILE SEQRES 10 A 298 LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET SEQRES 11 A 298 GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG ASP LEU SEQRES 12 A 298 ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL SEQRES 13 A 298 LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN SEQRES 14 A 298 ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY GLU SER SEQRES 15 A 298 PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER SEQRES 16 A 298 LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 298 VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SEQRES 18 A 298 SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP SEQRES 19 A 298 LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU SEQRES 20 A 298 LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS SEQRES 21 A 298 PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN SEQRES 22 A 298 ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA SEQRES 23 A 298 LEU ARG VAL ASP GLN ILE ARG ASP GLN MET ALA GLY SEQRES 1 B 298 ALA PHE GLU ASP ARG ASP PRO THR GLN PHE GLU GLU ARG SEQRES 2 B 298 HIS LEU LYS PHE LEU GLN GLN LEU GLY LYS GLY ASN PHE SEQRES 3 B 298 GLY SER VAL GLU MET CYS ARG TYR ASP PRO LEU GLN ASP SEQRES 4 B 298 ASN THR GLY GLU VAL VAL ALA VAL LYS LYS LEU GLN HIS SEQRES 5 B 298 SER THR GLU GLU HIS LEU ARG ASP PHE GLU ARG GLU ILE SEQRES 6 B 298 GLU ILE LEU LYS SER LEU GLN HIS ASP ASN ILE VAL LYS SEQRES 7 B 298 TYR LYS GLY VAL CYS TYR SER ALA GLY ARG ARG ASN LEU SEQRES 8 B 298 LYS LEU ILE MET GLU TYR LEU PRO TYR GLY SER LEU ARG SEQRES 9 B 298 ASP TYR LEU GLN ALA HIS ALA GLU ARG ILE ASP HIS ILE SEQRES 10 B 298 LYS LEU LEU GLN TYR THR SER GLN ILE CYS LYS GLY MET SEQRES 11 B 298 GLU TYR LEU GLY THR LYS ARG TYR ILE HIS ARG ASP LEU SEQRES 12 B 298 ALA THR ARG ASN ILE LEU VAL GLU ASN GLU ASN ARG VAL SEQRES 13 B 298 LYS ILE GLY ASP PHE GLY LEU THR LYS VAL LEU PRO GLN SEQRES 14 B 298 ASP LYS GLU PTR PTR LYS VAL LYS GLU PRO GLY GLU SER SEQRES 15 B 298 PRO ILE PHE TRP TYR ALA PRO GLU SER LEU THR GLU SER SEQRES 16 B 298 LYS PHE SER VAL ALA SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 B 298 VAL LEU TYR GLU LEU PHE THR TYR ILE GLU LYS SER LYS SEQRES 18 B 298 SER PRO PRO ALA GLU PHE MET ARG MET ILE GLY ASN ASP SEQRES 19 B 298 LYS GLN GLY GLN MET ILE VAL PHE HIS LEU ILE GLU LEU SEQRES 20 B 298 LEU LYS ASN ASN GLY ARG LEU PRO ARG PRO ASP GLY CYS SEQRES 21 B 298 PRO ASP GLU ILE TYR MET ILE MET THR GLU CYS TRP ASN SEQRES 22 B 298 ASN ASN VAL ASN GLN ARG PRO SER PHE ARG ASP LEU ALA SEQRES 23 B 298 LEU ARG VAL ASP GLN ILE ARG ASP GLN MET ALA GLY MODRES 4C61 PTR A 1007 TYR O-PHOSPHOTYROSINE MODRES 4C61 PTR A 1008 TYR O-PHOSPHOTYROSINE MODRES 4C61 PTR B 1007 TYR O-PHOSPHOTYROSINE MODRES 4C61 PTR B 1008 TYR O-PHOSPHOTYROSINE HET PTR A1007 16 HET PTR A1008 16 HET PTR B1007 16 HET PTR B1008 16 HET LMM A2133 27 HET ACT A2134 3 HET ACT A2135 3 HET LMM B3134 27 HET ACT B3135 3 HETNAM PTR O-PHOSPHOTYROSINE HETNAM LMM N2-[(1S)-1-(5-FLUOROPYRIMIDIN-2-YL)ETHYL]-7-METHYL-N4- HETNAM 2 LMM (1-METHYLIMIDAZOL-4-YL)THIENO[3,2-D]PYRIMIDINE-2,4- HETNAM 3 LMM DIAMINE HETNAM ACT ACETATE ION HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 4(C9 H12 N O6 P) FORMUL 3 LMM 2(C17 H17 F N8 S) FORMUL 4 ACT 3(C2 H3 O2 1-) FORMUL 8 HOH *199(H2 O) HELIX 1 1 GLU A 845 ARG A 847 5 3 HELIX 2 2 THR A 888 LEU A 905 1 18 HELIX 3 3 SER A 936 ALA A 945 1 10 HELIX 4 4 GLU A 946 ILE A 948 5 3 HELIX 5 5 ASP A 949 LYS A 970 1 22 HELIX 6 6 ALA A 978 ARG A 980 5 3 HELIX 7 7 PRO A 1017 TYR A 1021 5 5 HELIX 8 8 ALA A 1022 SER A 1029 1 8 HELIX 9 9 SER A 1032 THR A 1049 1 18 HELIX 10 10 GLU A 1052 LYS A 1055 5 4 HELIX 11 11 SER A 1056 GLY A 1066 1 11 HELIX 12 12 GLY A 1071 ASN A 1084 1 14 HELIX 13 13 PRO A 1095 TRP A 1106 1 12 HELIX 14 14 ASN A 1109 ARG A 1113 5 5 HELIX 15 15 SER A 1115 MET A 1130 1 16 HELIX 16 16 GLU B 845 ARG B 847 5 3 HELIX 17 17 HIS B 891 SER B 904 1 14 HELIX 18 18 SER B 936 ALA B 945 1 10 HELIX 19 19 GLU B 946 ILE B 948 5 3 HELIX 20 20 ASP B 949 LYS B 970 1 22 HELIX 21 21 ALA B 978 ARG B 980 5 3 HELIX 22 22 PRO B 1017 TYR B 1021 5 5 HELIX 23 23 ALA B 1022 SER B 1029 1 8 HELIX 24 24 SER B 1032 THR B 1049 1 18 HELIX 25 25 GLU B 1052 LYS B 1055 5 4 HELIX 26 26 SER B 1056 GLY B 1066 1 11 HELIX 27 27 GLY B 1071 ASN B 1084 1 14 HELIX 28 28 PRO B 1095 TRP B 1106 1 12 HELIX 29 29 ASN B 1109 ARG B 1113 5 5 HELIX 30 30 SER B 1115 GLN B 1129 1 15 SHEET 1 AA 5 LEU A 849 GLY A 856 0 SHEET 2 AA 5 SER A 862 TYR A 868 -1 O VAL A 863 N LEU A 855 SHEET 3 AA 5 GLU A 877 LYS A 883 -1 O GLU A 877 N TYR A 868 SHEET 4 AA 5 LYS A 926 GLU A 930 -1 O LEU A 927 N LYS A 882 SHEET 5 AA 5 TYR A 913 CYS A 917 -1 N LYS A 914 O ILE A 928 SHEET 1 AB 2 TYR A 972 ILE A 973 0 SHEET 2 AB 2 LYS A 999 VAL A1000 -1 O LYS A 999 N ILE A 973 SHEET 1 AC 2 ILE A 982 ASN A 986 0 SHEET 2 AC 2 ARG A 989 ILE A 992 -1 O ARG A 989 N GLU A 985 SHEET 1 AD 2 PTR A1008 LYS A1009 0 SHEET 2 AD 2 LYS A1030 PHE A1031 -1 O PHE A1031 N PTR A1008 SHEET 1 BA 5 LEU B 849 LYS B 857 0 SHEET 2 BA 5 SER B 862 TYR B 868 -1 O VAL B 863 N LEU B 855 SHEET 3 BA 5 GLU B 877 LYS B 883 -1 O GLU B 877 N TYR B 868 SHEET 4 BA 5 LYS B 926 GLU B 930 -1 O LEU B 927 N LYS B 882 SHEET 5 BA 5 TYR B 913 VAL B 916 -1 N LYS B 914 O ILE B 928 SHEET 1 BB 2 TYR B 972 ILE B 973 0 SHEET 2 BB 2 LYS B 999 VAL B1000 -1 O LYS B 999 N ILE B 973 SHEET 1 BC 2 ILE B 982 ASN B 986 0 SHEET 2 BC 2 ARG B 989 ILE B 992 -1 O ARG B 989 N GLU B 985 SHEET 1 BD 2 PTR B1008 LYS B1009 0 SHEET 2 BD 2 LYS B1030 PHE B1031 -1 O PHE B1031 N PTR B1008 LINK C GLU A1006 N PTR A1007 1555 1555 1.34 LINK C PTR A1007 N PTR A1008 1555 1555 1.35 LINK C PTR A1008 N LYS A1009 1555 1555 1.35 LINK C GLU B1006 N PTR B1007 1555 1555 1.34 LINK C PTR B1007 N PTR B1008 1555 1555 1.33 LINK C PTR B1008 N LYS B1009 1555 1555 1.34 SITE 1 AC1 13 LEU A 855 ALA A 880 MET A 929 GLU A 930 SITE 2 AC1 13 TYR A 931 LEU A 932 GLY A 935 ARG A 980 SITE 3 AC1 13 ASN A 981 LEU A 983 GLY A 993 ASP A 994 SITE 4 AC1 13 HOH A2038 SITE 1 AC2 10 LEU B 855 ALA B 880 GLU B 930 TYR B 931 SITE 2 AC2 10 LEU B 932 GLY B 935 ARG B 980 ASN B 981 SITE 3 AC2 10 LEU B 983 GLY B 993 SITE 1 AC3 4 TYR A 931 PRO A 933 ARG B1090 GLY B1093 SITE 1 AC4 4 PHE A 851 GLU A 864 LYS A 926 ACT A2135 SITE 1 AC5 2 GLU A 864 ACT A2134 CRYST1 43.880 127.090 135.210 90.00 97.33 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022789 0.000000 0.002932 0.00000 SCALE2 0.000000 0.007868 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007457 0.00000 MASTER 449 0 9 30 22 0 10 6 0 0 0 46 END